Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| Revenues | 3,749.0 | 4,552.0 | 4,425.0 | 4,684.0 | 4,702.0 | 3,938.0 | 2,376.0 | 1,633.0 |
| Revenue growth | -17.6% | 2.9% | -5.5% | -0.4% | 19.4% | 65.7% | 45.5% | 16.2% |
| Cost of goods sold | 601.0 | 638.0 | 613.0 | 649.0 | 664.0 | -115.0 | -558.0 | -638.0 |
| Gross profit | 3,148.0 | 3,914.0 | 3,812.0 | 4,035.0 | 4,038.0 | 4,053.0 | 2,934.0 | 2,271.0 |
| Gross margin | 84.0% | 86.0% | 86.1% | 86.1% | 85.9% | 102.9% | 123.5% | 139.1% |
| Selling, general and administrative | 245.0 | 303.0 | 296.0 | 313.0 | 305.0 | | 110.0 | 173.0 |
| Sales and marketing | | | | | | 172.0 | | |
| Research and development | 176.0 | 188.0 | 206.0 | 225.0 | 317.0 | 264.0 | | |
| EBITA | 663.0 | 902.0 | 797.0 | 346.0 | 1,060.0 | 889.0 | 234.0 | 44.0 |
| EBITA margin | 17.7% | 19.8% | 18.0% | 7.4% | 22.5% | 22.6% | 9.8% | 2.7% |
| Amortization of intangibles | 62.0 | 61.0 | 58.0 | 58.0 | 57.0 | | | |
| EBIT | 601.0 | 841.0 | 739.0 | 288.0 | 1,003.0 | 889.0 | 234.0 | 44.0 |
| EBIT margin | 16.0% | 18.5% | 16.7% | 6.1% | 21.3% | 22.6% | 9.8% | 2.7% |
| Pre-tax income | 470.0 | 725.0 | 686.0 | 205.0 | -645.0 | 892.0 | 84.0 | 91.0 |
| Income taxes | 105.0 | 122.0 | 128.0 | -7.0 | 95.0 | 243.0 | -121.0 | 48.0 |
| Tax rate | 22.3% | 16.8% | 18.7% | | | 27.2% | | 52.7% |
| Earnings from continuing ops | 382.0 | 587.0 | 539.0 | 205.0 | -1,475.0 | 659.0 | 205.0 | 41.0 |
| Earnings from discontinued ops | | | | | 7.0 | 4.0 | | |
| Net income | 382.0 | 587.0 | 539.0 | 205.0 | -1,468.0 | 663.0 | 205.0 | 41.0 |
| Net margin | 10.2% | 12.9% | 12.2% | 4.4% | -31.2% | 16.8% | 8.6% | 2.5% |
| |
| Diluted EPS | $1.53 | $2.23 | $2.06 | $0.79 | ($5.57) | $2.77 | $1.37 | $0.35 |
| Shares outstanding (diluted) | 250.0 | 263.0 | 262.0 | 261.0 | 265.0 | 238.0 | 150.0 | 116.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|